<?xml version="1.0" encoding="UTF-8"?>
<p id="Par6">In the midst of the pandemic, the need for accurate information is urgent. The rheumatology community has responded rapidly, with a group of over 300 rheumatologists, scientists and patients from around the world forming 
 <ext-link ext-link-type="uri" xlink:href="https://rheum-covid.org/" xmlns:xlink="http://www.w3.org/1999/xlink">The COVID-19 Global Rheumatology Alliance</ext-link> over the course of a few days. Remarkably, the idea for the alliance was initially formed through conversations on social media, with Twitter facilitating a rapid information exchange between researchers and clinicians. International collaborators from across six continents were recruited from personal and professional networks to provide complementary areas of expertise. Over a period of days, alliance members swiftly began work on four distinct projects that would address the overall goal of efficiently gathering data regarding patients with rheumatic diseases and immunosuppressive medications during the rapidly evolving pandemic: a registry for physicians around the world to report cases of COVID-19; analyses of insurer health claims data; systematic literature reviews; and partnerships with researchers who were conducting patient-facing research. Over 100 professional societies, institutions and organizations from around the world have joined the alliance and are supporting its mission, including this journal.
</p>
